Neonc Technologies Holdings (NTHI) Cash & Equivalents (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Cash & Equivalents of $138601.0 for Q1 2026, down 97.45% year-over-year from $5.4 million in Q1 2025, and up 136.0% quarter-over-quarter from $58729.0 in Q4 2025.
Neonc Technologies Holdings (NTHI) Cash & Equivalents (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Cash & Equivalents for 3 consecutive years, with $138601.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 97.45% year-over-year to $138601.0; the TTM figure through Mar 2026 stood at $138601.0 (down 97.45% YoY), while the FY2025 annual figure was $58729.0, down 9.5% from the prior year.
- Cash & Equivalents advanced to $138601.0 in Q1 2026 per NTHI's latest filing, from $58729.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $5.4 million in Q1 2025 and bottomed at $58729.0 in Q4 2025.
- Historically, Cash & Equivalents has averaged $1.2 million across 3 years, with a median of $131820.0 in 2025.
- Annual changes were most pronounced in 2025 — Cash & Equivalents dropped 9.5% — and 2026, when it plunged 97.45%.
- Neonc Technologies Holdings' Cash & Equivalents stood at $64893.0 in 2024, then declined by 9.5% to $58729.0 in 2025, then surged by 136.0% to $138601.0 in 2026.
- Business Quant data shows NTHI's Cash & Equivalents at $138601.0 in Q1 2026, $58729.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 3.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.72 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.71 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.93 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 544.80 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.99 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 138,601.00 |
| Dec 31, 2025 | 58,729.00 |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 125,039.00 |
| Mar 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 64,893.00 |